1. Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer

   • Vittorio Gebbia
   • Aurelia Guarini
   • Alberto Firenze

   Review Open access 04 June 2021 Pages: 295 - 308

   

2. A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist

   • Andrea S. Melani
   • Albano Simona
   • Elena Bargagli

   Review Open access 06 June 2021 Pages: 309 - 324

   

3. A Comprehensive Review of Sarcoidosis Treatment for Pulmonologists

   • Andrea S. Melani
   • Caterina Bigliazzi
   • Elena Bargagli

   Review Open access 18 June 2021 Pages: 325 - 344

   

4. Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective

   • Amy H. Y. Chan
   • Roy A. Pleasants
   • Rajan Merchant

   Review Open access 11 August 2021 Pages: 345 - 376

   

5. CFTR Modulator Therapy and Its Impact on Lung Transplantation in Cystic Fibrosis

   • Christian Benden
   • Carsten Schwarz

   Review Open access 18 August 2021 Pages: 377 - 393

6. Cannabis and Lung Health: Does the Bad Outweigh the Good?

   • Alan G. Kaplan

   Review Open access 25 October 2021 Pages: 395 - 408

   

7. Switching to the Dry-Powder Inhaler Easyhaler^®: A Narrative Review of the Evidence

   • Federico Lavorini
   • Jerzy Chudek
   • Tari Haahtela

   Review Open access 27 September 2021 Pages: 409 - 427

   

8. An Observational Study Assessing Changes in Health and Functional Status in Patients with Chronic Obstructive Pulmonary Disease (COPD) During Therapy with Spiolto^® Respimat^® in Everyday Clinical Practice: The Greek ELLACTO Study

   • Epaminondas Kosmas
   • Iraklis Titopoulos
   • Nikos Nikas

   Original Research Open access 03 May 2021 Pages: 429 - 443

   

9. Period-to-Period Variability of Moderate/Severe Obstructive Sleep Apnoea

   • Charlotte A. Wigston
   • John R. Stradling
   • Chris D. Turnbull

   Original Research Open access 15 May 2021 Pages: 445 - 453

   

10. Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization

    • Dominique Hubert
    • Christophe Marguet
    • the BRIO Study Group

    Original Research Open access 08 June 2021 Pages: 455 - 468

    

11. Correction to: Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization

    • Dominique Hubert
    • Christophe Marguet
    • the BRIO Study Group

    Correction Open access 14 July 2021 Pages: 469 - 470

12. Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial

    • Fernando J. Martinez
    • Amna Sadaf Afzal
    • the Chronic Cough in IPF Study Group

    Original Research Open access 21 June 2021 Pages: 471 - 486

    

13. Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study

    • David A. Hall
    • Kate Hanrott
    • Jens M. Hohlfeld

    Original Research Open access 26 June 2021 Pages: 487 - 501

    

14. Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD

    • Thomas M. Siler
    • Claire Hohenwarter
    • Sanjay Sharma

    Original Research Open access 07 July 2021 Pages: 503 - 516

    

15. Burden of Pneumonia Among Hospitalized Patients with Influenza: Real-World Evidence from a US Managed Care Population

    • Susan C. Bolge
    • Cynthia Gutierrez
    • Ding He

    Original Research Open access 16 August 2021 Pages: 517 - 532

    

16. Use of a Digital Chronic Obstructive Pulmonary Disease Respiratory Tracker in a Primary Care Setting: A Feasibility Study

    • Gerard J. Criner
    • Therese Cole
    • Ileen Gilbert

    Original Research Open access 31 August 2021 Pages: 533 - 547

    

17. The Effect of Adding a Training Device and Smartphone Application to Traditional Verbal Counseling in Asthmatic Children

    • Sara M. Tony
    • Mona A. Abdelrahman
    • Mohamed E. A. Abdelrahim

    Original Research Open access 13 October 2021 Pages: 549 - 562

    

18. The Impact of Risk Factors on Treatment Outcomes of Nosocomial Pneumonia Due to Gram-Negative Bacteria in the Intensive Care Unit

    • Thu Vo-Pham-Minh
    • Van Duong-Thi-Thanh
    • Sy Duong-Quy

    Original Research Open access 15 October 2021 Pages: 563 - 574

    

19. Real-World Analysis of Treatment Patterns Among Hospitalized Patients with Pulmonary Arterial Hypertension

    • Adesuwa Ogbomo
    • Yuen Tsang
    • Sumeet Panjabi

    Original Research Open access 26 October 2021 Pages: 575 - 590

    

20. Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study)

    • Marika Leving
    • Hans Wouters
    • Janwillem Kocks

    Study Protocol Open access 17 September 2021 Pages: 591 - 606